gettyKey FactsOxford University has begun searching for participants in the early-stage trial, the Financial Times reported Thursday, which will take around four months to complete and could begin as early as next week. MailOnline has approached Oxford University and AstraZeneca for comment. The early-stage trial will enroll adults aged 18 to 40 from the Oxford area, and researchers will conduct four months of follow-up, according to a release posted Thursday. Forbes has reached out to AstraZeneca and Oxford for comment. All participants will receive one dose of the vaccine, with half set to receive a booster dose at a later point in time.
Forbes is taking on a stroll in a park.
( z0 stroll :ARG0 ( z1 person :name ( z2 name :op "Forbes" ) ) :ARG1 ( z3 park ) )
(z0 / stroll-01
    :ARG0 (z1 / person
              :name (z2 / name
                        :op1 "Forbes"))
    :ARG1 (z3 / park))
Forbes is taking on a stroll in a park .
z1 :name z2
z2 :op1 0
z0 :ARG0 z1
z0 :ARG1 z3